Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.
about
Beta blockers for essential tremorAlprazolam for essential tremorAlprazolam for essential tremorZonisamide for essential tremorTopiramate for essential tremorPregabalin for essential tremorBeta blockers for essential tremor"Hairy baskets" associated with degenerative Purkinje cell changes in essential tremorEvidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of NeurologyFlexible Neural Electrode Array Based-on Porous Graphene for Cortical Microstimulation and SensingSurgery for Dystonia and Tremor.Imaging findings in MR imaging-guided focused ultrasound treatment for patients with essential tremor.Fertility in essential tremor. Data from population-based and clinical sourcesFragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatmentIsolated head tremor: part of the clinical spectrum of essential tremor? Data from population-based and clinic-based case samples.How are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings.Fragile X-Associated Tremor/Ataxia Syndrome: From Molecular Pathogenesis to Development of Therapeutics.Antihypertensive agents and risk of Parkinson's disease, essential tremor and dementia: a population-based prospective study (NEDICES).Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremorDefective dentate nucleus GABA receptors in essential tremor.Target identification for stereotactic thalamotomy using diffusion tractography.Diagnosis and treatment of common forms of tremor.Survey of medication usage patterns among essential tremor patients: movement disorder specialists vs. general neurologists.Neuroimaging essentials in essential tremor: a systematic review.Emerging strategies in the management of essential tremor.Pharmacologic management of essential tremor.Diagnosis and management of essential tremor and dystonic tremor.Treatment of Essential Tremor: Are there Issues We are Overlooking?Use of antiepileptic drugs for hyperkinetic movement disorders.Guidelines for management of essential tremor.A patient with tremor, part 2: from diagnosis to treatment.Brain biochemistry in autopsied patients with essential tremorHigh-Dose Benzodiazepine Dependence: A Qualitative Study of Patients' Perceptions on Initiation, Reasons for Use, and Obtainment.Functional Ability Improved in Essential Tremor by IncobotulinumtoxinA Injections Using Kinematically Determined Biomechanical Patterns - A New FutureChiropractic management of essential tremor and migraine: a case report.A computerized tablet system for evaluating treatment of essential tremor by magnetic resonance guided focused ultrasound.Wireless fast-scan cyclic voltammetry to monitor adenosine in patients with essential tremor during deep brain stimulationBilateral cerebellar activation in unilaterally challenged essential tremor.
P2860
Q24186239-7FE73E01-9E02-4F65-BC88-36520199845CQ24187196-08AB7A59-573F-43BC-85B3-087D7056032AQ24201430-3FF741D2-4622-4EB4-9FC9-D7595630A71AQ24201497-E7115F7F-89F4-4063-A408-0E2899326E1AQ24201606-D87E768D-9799-4F4F-8415-1521AC9A8943Q24203614-EC5DE170-6577-4B89-BFAD-0173F0A36543Q24241056-6C0F709E-BBDC-4F04-8442-1527FBAC4233Q24628115-736C09D4-75DD-4ABF-BD32-A6E4B806E022Q24631487-5E4E8B08-958F-4A4F-96D6-CAAB4D2629E3Q27347779-2317F0B1-4EBA-43A4-B717-2424B6984102Q30277621-847BF6EA-A9E3-43F8-9C67-86D3E12144CEQ30457269-29EB21FD-C0D1-4991-8E57-DF9ED152D94DQ33368568-AC080D32-3877-4600-9209-61FD53CEF941Q33477846-67E6871F-97DD-4830-96BE-FFA02B26CD12Q33507936-73A418A4-3EFE-4378-8758-39A70BD4CEA5Q33523378-AE39E948-0CD2-4A96-B49D-104CB5E35D49Q33639492-34B13FE9-E727-4E88-83E4-B28AD7ECEA63Q33678373-AD7F8424-1218-4BE0-A765-82772241D4D1Q33769128-5571D85A-7A3A-4A4E-904F-058D14A84C25Q33953965-F43698F7-9990-4E61-BE46-C7106ED18318Q33983073-1F6CF98B-07FA-41E4-8CEB-3176BB1E4921Q34029544-FE62A25B-42FC-4924-AFEE-3F8370264D5EQ34125379-F1C83EA6-034E-429F-A2D2-2C5406A267A0Q34164665-E904F2C3-C215-4D17-8F7F-EE86C1059B3CQ34238588-F30B8911-3847-46DA-A8A8-79EA763A2728Q34431116-B1751983-F4BF-4707-8BBC-67C4A0672D0FQ34554826-3F15E9DB-9885-4B22-9E39-0FEF535C8DF1Q34617734-396921CE-B96F-4CCE-80B8-54C52C54018DQ34625978-C0E3A41C-020F-4308-AB5C-4F1142AE28B3Q34635365-C66DD5C7-55DE-4D54-84B5-FBF5C8B4BC62Q34829294-93F61740-0950-4A2E-920A-6F496C9D16E8Q35153016-8D204E0F-706C-4E12-8D4B-567CE77DB7EBQ35255502-95316FD1-0DC6-44B2-A554-59AAA5EC1CC6Q35680914-6B545A7A-619F-4E19-841E-CF3DB2B41508Q35837717-25C24CE3-3EEF-4ACD-B27C-D5D37EB405DCQ35996232-C352D942-5DE1-4CBB-87EE-09442A751938Q36012931-3A4D4243-C562-4932-880E-B48FD8BC715AQ36347948-673CBCF7-8B4F-4942-B54B-93BB5AAA82FEQ36513075-86660FE2-828B-40B2-BC5A-DF2D783CBC3DQ36518191-4B190007-EB64-42D7-A978-BA4BCF475ED9
P2860
Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Practice parameter: therapies ...... American Academy of Neurology.
@ast
Practice parameter: therapies ...... American Academy of Neurology.
@en
type
label
Practice parameter: therapies ...... American Academy of Neurology.
@ast
Practice parameter: therapies ...... American Academy of Neurology.
@en
prefLabel
Practice parameter: therapies ...... American Academy of Neurology.
@ast
Practice parameter: therapies ...... American Academy of Neurology.
@en
P2093
P1433
P1476
Practice parameter: therapies ...... American Academy of Neurology.
@en
P2093
G S Gronseth
K L Sullivan
Quality Standards Subcommittee of the American Academy of Neurology
R A Hauser
T A Zesiewicz
W J Weiner
P304
P356
10.1212/01.WNL.0000163769.28552.CD
P407
P577
2005-06-22T00:00:00Z